{
    "eid": "2-s2.0-85072125992",
    "title": "The Role of Aberrations in the Immune-Inflammatory Response System (IRS) and the Compensatory Immune-Regulatory Reflex System (CIRS) in Different Phenotypes of Schizophrenia: the IRS-CIRS Theory of Schizophrenia",
    "cover-date": "2020-02-01",
    "subject-areas": [
        {
            "@_fa": "true",
            "$": "Neurology",
            "@code": "2808",
            "@abbrev": "NEUR"
        },
        {
            "@_fa": "true",
            "$": "Cellular and Molecular Neuroscience",
            "@code": "2804",
            "@abbrev": "NEUR"
        }
    ],
    "keywords": [
        "CIRS",
        "Cytokines",
        "Immune regulatory",
        "Immune system",
        "Immunology",
        "Inflammation",
        "Psychiatry",
        "Psychosis",
        "Schizophrenia"
    ],
    "authors": [
        "Chutima Roomruangwong",
        "Cristiano Noto",
        "Buranee Kanchanatawan",
        "George Anderson",
        "Marta Kubera",
        "Andre F. Carvalho",
        "Michael Maes"
    ],
    "citedby-count": 74,
    "ref-count": 172,
    "ref-list": [
        "Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015",
        "A systematic review and meta-analysis of recovery in schizophrenia",
        "How well do patients with a first episode of schizophrenia respond to antipsychotics: a systematic review and meta-analysis",
        "A typological model of schizophrenia based on age at onset, sex and familial morbidity",
        "Sex differences in the risk of schizophrenia: evidence from meta-analysis",
        "Adoption studies of schizophrenia",
        "Schizophrenia as a complex trait: evidence from a meta-analysis of twin studies",
        "Common variants conferring risk of schizophrenia: a pathway analysis of GWAS data",
        "Major histocompatibility complex I in brain development and schizophrenia",
        "Regulation of immune-modulatory genes in left superior temporal cortex of schizophrenia patients: a genome-wide microarray study",
        "Obstetric complications and schizophrenia: historical and meta-analytic review",
        "Prenatal exposure to environmental insults and enhanced risk of developing schizophrenia and autism spectrum disorder: Focus on biological pathways and epigenetic mechanisms",
        "Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959\u20131961",
        "Schizophrenia: linking prenatal infection to cytokines, the tryptophan catabolite (TRYCAT) pathway, NMDA receptor hypofunction, neurodevelopment and neuroprogression",
        "Prenatal infection as a risk factor for schizophrenia",
        "Toxoplasma gondii and schizophrenia",
        "Schizophrenia as an immunologic disorder. I. Demonstration of antibrain globulins by fluorescent antibody techniques",
        "The macrophage-T-lymphocyte theory of schizophrenia: additional evidence",
        "Acute phase proteins in schizophrenia, mania and major depression: modulation by psychotropic drugs",
        "Immune-inflammatory markers in schizophrenia: comparison to normal controls and effects of clozapine",
        "A meta-analysis of blood cytokine network alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder and depression",
        "Immune involvement in the pathogenesis of schizophrenia: a meta-analysis on postmortem brain studies",
        "Cerebrospinal fluid markers of inflammation and infections in schizophrenia and affective disorders: a systematic review and meta-analysis",
        "Meta-analysis of cerebrospinal fluid cytokine and tryptophan catabolite alterations in psychiatric patients: comparisons between schizophrenia, bipolar disorder, and depression",
        "Transcriptome sequencing study implicates immune-related genes differentially expressed in schizophrenia: new data and a meta-analysis",
        "The emerging immunogenetic architecture of schizophrenia",
        "Effects of Risperidone on Cytokine Profile in Drug-Naive First-Episode Psychosis",
        "Angiotensin converting enzyme activity is positively associated with IL-17a levels in patients with schizophrenia",
        "Plasma levels of Th17-related cytokines and complement C3 correlated with aggressive behavior in patients with schizophrenia",
        "The Compensatory Immune-Regulatory Reflex System (CIRS) in Depression and Bipolar Disorder",
        "Effects of depression on the cytokine profile in drug na\u00efve first-episode psychosis",
        "Th1, Th2 and Th3 cytokine alteration in schizophrenia",
        "Meta-analysis of cytokine alterations in schizophrenia: clinical status and antipsychotic effects",
        "Targeting IL-1 in depression",
        "The M1 and M2 paradigm of macrophage activation: time for reassessment",
        "Targeting classical IL-6 signalling or IL-6 trans-signalling in depression?",
        "TNF alpha and the TNF receptor superfamily: structure-function relationship(s)",
        "Assay of soluble tumor necrosis factor receptors",
        "Serum level of soluble tumor necrosis factor receptor II (sTNF-R75) is apparently an index of overall monocyte-related infectious and inflammatory activity",
        "A derivative of the plasma protease inhibitor alpha(2)-macroglobulin regulates the response to peripheral nerve injury",
        "Alpha-2-macroglobulin as a radioprotective agent: a review",
        "Increased inflammatory markers identified in the dorsolateral prefrontal cortex of individuals with schizophrenia",
        "Inflammatory cytokine alterations in schizophrenia: a systematic quantitative review",
        "Immuno-inflammatory, oxidative and nitrosative stress, and neuroprogressive pathways in the etiology, course and treatment of schizophrenia",
        "Developmental neuroinflammation and schizophrenia",
        "Haptoglobin polymorphism and schizophrenia: genetic variation on chromosome 16",
        "Haptoglobin polymorphism and peripheral arterial occlusive disease",
        "Haptoglobin genotype modulates the balance of Th1/Th2 cytokines produced by macrophages exposed to free hemoglobin",
        "The haptoglobin 2-2 genotype is associated with inflammation and carotid artery intima-media thickness",
        "Haptoglobin, inflammation and disease",
        "Elevated CSF levels of interleukin-2 in neuroleptic-free schizophrenic patients",
        "Serum interleukin-6 concentration in schizophrenia: elevation associated with duration of illness",
        "Plasma levels of interleukin-1 beta and interleukin-6 in schizophrenia, other psychoses, and affective disorders",
        "Plasma-soluble interleukin-2 and transferrin receptor in schizophrenia and major depression",
        "Increased interleukin-1 and interleukin-3 like activity in schizophrenic patients",
        "Lower plasma CC16, a natural anti-inflammatory protein, and increased plasma interleukin-1 receptor antagonist in schizophrenia: effects of antipsychotic drugs",
        "Inflammation and schizophrenia",
        "Increased serum levels of inflammatory markers in chronic institutionalized patients with schizophrenia",
        "Similar immune profile in bipolar disorder and schizophrenia: selective increase in soluble tumor necrosis factor receptor I and von Willebrand factor",
        "Interleukin 1 receptor antagonist and soluble tumor necrosis factor receptor 1 are associated with general severity and psychotic symptoms in schizophrenia and bipolar disorder",
        "Circulating levels of sTNFR1 as a marker of severe clinical course in schizophrenia",
        "Increased serum interleukin-8 and interleukin-10 in schizophrenic patients resistant to treatment with neuroleptics and the stimulatory effects of clozapine on serum leukemia inhibitory factor receptor",
        "Elevated interleukin-2, interleukin-6 and interleukin-8 serum levels in neuroleptic-free schizophrenia: association with psychopathology",
        "Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia",
        "Increased serum levels of CCL11/eotaxin in schizophrenia",
        "Increased level of serum cytokines, chemokines and adipokines in patients with schizophrenia is associated with disease and metabolic syndrome",
        "Dysregulation of chemo-cytokine production in schizophrenic patients versus healthy controls",
        "Chemokines and chemokine receptors in mood disorders, schizophrenia, and cognitive impairment: a systematic review of biomarker studies",
        "Eotaxin, an Endogenous Cognitive Deteriorating Chemokine (ECDC), Is a Major Contributor to Cognitive Decline in Normal People and to Executive, Memory, and Sustained Attention Deficits, Formal Thought Disorders, and Psychopathology in Schizophrenia Patients",
        "Monocyte chemoattractant protein 1 acts as a T-lymphocyte chemoattractant",
        "Kynurenic acid in schizophrenia: a systematic review and meta-analysis",
        "Deficit schizophrenia is characterized by defects in IgM-mediated responses to tryptophan catabolites (TRYCATs): A paradigm shift towards defects in natural self-regulatory immune responses coupled with mucosa-derived TRYCAT pathway activation",
        "Decreased plasma tryptophan and tryptophan/large neutral amino acid ratio in patients with neuroleptic-resistant schizophrenia: relationship to plasma cortisol concentration",
        "Kynurenine pathway in psychosis: evidence of increased tryptophan degradation",
        "Increased levels of kynurenine and kynurenic acid in the CSF of patients with schizophrenia",
        "Deficit, but not nondeficit, schizophrenia is characterized by mucosa-associated activation of the tryptophan catabolite (TRYCAT) pathway with highly specific increases in IgA responses directed to picolinic, xanthurenic, and quinolinic acid",
        "The new \u20185-HT\u2019 hypothesis of depression: Cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute to the onset of depression",
        "Tryptophan deprivation sensitizes activated T cells to apoptosis prior to cell division",
        "The immune effects of TRYCATs (tryptophan catabolites along the IDO pathway): relevance for depression - and other conditions characterized by tryptophan depletion induced by inflammation",
        "Inflammatory biomarkers in individuals at clinical high risk for psychosis (CHR-P): State or trait?",
        "Peripheral immuno-inflammatory abnormalities in ultra-high risk of developing psychosis",
        "Increased serum interleukin-6 levels in early stages of psychosis: associations with at-risk mental states and the severity of psychotic symptoms",
        "Systemic inflammation and intelligence in early adulthood and subsequent risk of schizophrenia and other non-affective psychoses: a longitudinal cohort and co-relative study",
        "Olanzapine versus haloperidol treatment in first-episode psychosis",
        "Cognitive functioning in first-episode schizophrenia: MATRICS consensus cognitive battery (MCCB) profile of impairment",
        "Brain-wide analysis of functional connectivity in first-episode and chronic stages of schizophrenia",
        "Patterns of regional gray matter loss at different stages of schizophrenia: a multisite, cross-sectional VBM study in first-episode and chronic illness",
        "First vs multiple episode schizophrenia: two-year outcome of intermittent and maintenance medication strategies",
        "Peripheral blood gene expression of acute phase proteins in people with first episode psychosis",
        "Pro-/anti-inflammatory dysregulation in patients with first episode of psychosis: toward an integrative inflammatory hypothesis of schizophrenia",
        "Analysis of the changes of serum high mobility group protein B1 and cytokines in first-episode schizophrenia patients",
        "Increased interleukin-6 and tumor necrosis factor alpha in first episode schizophrenia patients versus healthy controls",
        "Cytokine alterations in first-episode schizophrenia patients before and after antipsychotic treatment",
        "Interleukin 18 and cognitive impairment in first episode and drug na\u00efve schizophrenia versus healthy controls",
        "Altered serum levels of interleukin-3 in first-episode drug-naive and chronic medicated schizophrenia",
        "Elevated serum level of type-2 cytokine and low IL-17 in first episode psychosis and schizophrenia in relapse",
        "Lowered paraoxonase 1 (PON1) activity is associated with increased cytokine levels in drug na\u00efve first episode psychosis",
        "Investigation of serum cytokine levels and cytokine production in whole blood cultures of paranoid schizophrenic patients",
        "Similarities in serum oxidative stress markers and inflammatory cytokines in patients with overt schizophrenia at early and late stages of chronicity",
        "Decreased interleukin-10 serum levels in first-episode drug-na\u00efve schizophrenia: relationship to psychopathology",
        "Biological properties of interleukin 10",
        "Oxidative Stress and Inflammation in First-Episode Psychosis: A Systematic Review and Meta-analysis",
        "Cytokine function in medication-naive first episode psychosis: a systematic review and meta-analysis",
        "Serum and gene expression profile of cytokines in first-episode psychosis",
        "Depression, cytokine, and cytokine by treatment interactions modulate gene expression in antipsychotic na\u00efve first episode psychosis",
        "Cerebrospinal fluid kynurenic acid in male and female controls\u2014correlation with monoamine metabolites and influences of confounding factors",
        "A review of vulnerability and risks for schizophrenia: beyond the two hit hypothesis",
        "Human endogenous retroviral pol RNA and protein detected and identified in the blood of individuals with schizophrenia",
        "Retroviral RNA identified in the cerebrospinal fluids and brains of individuals with schizophrenia",
        "HERV-W-related RNA detected in plasma from individuals with recent-onset schizophrenia or schizoaffective disorder",
        "Elevated levels of human endogenous retrovirus-W transcripts in blood cells from patients with first episode schizophrenia",
        "Antibodies to retroviruses in recent onset psychosis and multi-episode schizophrenia",
        "The human endogenous retrovirus envelope glycoprotein, syncytin-1, regulates neuroinflammation and its receptor expression in multiple sclerosis: a role for endoplasmic reticulum chaperones in astrocytes",
        "Infectious agents associated with schizophrenia: a meta-analysis",
        "The association of infectious agents and schizophrenia",
        "The human endogenous retrovirus link between genes and environment in multiple sclerosis and in multifactorial diseases associating neuroinflammation",
        "Altered transcriptional activity of human endogenous retroviruses in neuroepithelial cells after infection with Toxoplasma gondii",
        "Transcriptional derepression of the ERVWE1 locus following influenza A virus infection",
        "Toxoplasma gondii and other risk factors for schizophrenia: an update",
        "The envelope protein of a human endogenous retrovirus-W family activates innate immunity through CD14/TLR4 and promotes Th1-like responses",
        "T-cell subsets in schizophrenia: a comparison between drug-naive first episode patients and chronic schizophrenic patients",
        "Oxidative and nitrosative stress biomarkers in chronic schizophrenia",
        "Elevated interleukin-18 serum levels in chronic schizophrenia: association with psychopathology",
        "The inflammatory response system in treatment-resistant schizophrenia: increased serum interleukin-6",
        "Effects of atypical antipsychotics on the inflammatory response system in schizophrenic patients resistant to treatment with typical neuroleptics",
        "MCP-1 gene (SCYA2) and schizophrenia: a case-control association study",
        "A novel polymorphism in the MCP-1 gene regulatory region that influences MCP-1 expression",
        "The evolution of depression and suicidality in first episode psychosis",
        "Depressive symptoms in first-episode psychosis: a 10-year follow-up study",
        "In schizophrenia, depression, anxiety, and physiosomatic symptoms are strongly related to psychotic symptoms and excitation, impairments in episodic memory, and increased production of neurotoxic tryptophan catabolites: a multivariate and machine learning study",
        "Predictive values of neurocognition and negative symptoms on functional outcome in schizophrenia: a longitudinal first-episode study with 7-year follow-up",
        "Deficit schizophrenia: an update",
        "Changes in tryptophan catabolite (TRYCAT) pathway patterning are associated with mild impairments in declarative memory in schizophrenia and deficits in semantic and episodic memory coupled with increased false-memory creation in deficit schizophrenia",
        "Peripheral interleukin-2 level is associated with negative symptoms and cognitive performance in schizophrenia",
        "Persistently increased serum soluble interleukin-2 receptors in continuously ill patients with schizophrenia",
        "Relationships between interleukins, neurotransmitters and psychopathology in drug-free male schizophrenics",
        "Serum IL-4 and IL-10 levels correlate with the symptoms of the drug-naive adolescents with first episode, early onset schizophrenia",
        "Impact of peripheral levels of chemokines, BDNF and oxidative markers on cognition in individuals with schizophrenia",
        "Infiltration of tumours by macrophages and dendritic cells: tumour-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes",
        "The Th2-hypothesis of schizophrenia: a strategy to identify a subgroup of schizophrenia caused by immune mechanisms",
        "Immunological treatment options for schizophrenia",
        "Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers",
        "Cytokines in schizophrenia",
        "Cytokines in systemic lupus erythematosus: far beyond Th1/Th2 dualism lupus: cytokine profiles",
        "New possible biomarkers for diagnosis of infections and diagnostic distinction between bacterial and viral infections in children",
        "Interferons and other cytokines in bacterial infections",
        "Mechanistic explanations how cell-mediated immune activation, inflammation and oxidative and nitrosative stress pathways and their sequels and concomitants play a role in the pathophysiology of unipolar depression",
        "Neuroprogression in schizophrenia: pathways underpinning clinical staging and therapeutic corollaries",
        "Cytokines and schizophrenia: microglia hypothesis of schizophrenia",
        "Progressive and interrelated functional and structural evidence of post-onset brain reduction in schizophrenia",
        "Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis",
        "Interleukin-17 and brain injury in stroke",
        "Interleukin-8 and interleukin-10, brain volume and microstructure, and the influence of calorie restriction in old rhesus macaques",
        "Chemokine interleukin-8 (IL-8) in Alzheimer\u2019s and other neurodegenerative diseases",
        "Induction of indolamine 2,3-dioxygenase and kynurenine 3-monooxygenase in rat brain following a systemic inflammatory challenge: a role for IFN-gamma?",
        "IL-4 in the brain: a cytokine to remember",
        "Neuroimmunology of the Interleukins 13 and 4",
        "IL-5 induces proliferation and activation of microglia via an unknown receptor",
        "The Effects of Tryptophan Catabolites on Negative Symptoms and Deficit Schizophrenia are Partly Mediated by Executive Impairments: Results of Partial Least Squares Path Modeling",
        "The challenge of psychiatric nosology and diagnosis",
        "Deficit schizophrenia is a discrete diagnostic category defined by neuro-immune and neurocognitive features: results of supervised machine learning",
        "Diagnostic classifications in depression and somatization should include biomarkers, such as disorders in the tryptophan catabolite (TRYCAT) pathway",
        "Clinical subtypes of unipolar depression: part II. Quantitative and qualitative clinical differences between the vital and nonvital depression groups",
        "Myalgic encephalomyelitis (ME), chronic fatigue syndrome (CFS), and chronic fatigue (CF) are distinguished accurately: results of supervised learning techniques applied on clinical and inflammatory data",
        "Development of a Novel Staging Model for Affective Disorders Using Partial Least Squares Bootstrapping: Effects of Lipid-Associated Antioxidant Defenses and Neuro-Oxidative Stress"
    ],
    "affiliation": [
        {
            "affiliation-city": "Sao Paulo",
            "@id": "60014992",
            "affilname": "Universidade Federal de S\u00e3o Paulo",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014992",
            "affiliation-country": "Brazil"
        },
        {
            "affiliation-city": "Plovdiv",
            "@id": "60031890",
            "affilname": "Medical University of Plovdiv",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60031890",
            "affiliation-country": "Bulgaria"
        },
        {
            "affiliation-city": "Bangkok",
            "@id": "60028190",
            "affilname": "Chulalongkorn University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60028190",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Geelong",
            "@id": "60018805",
            "affilname": "Deakin University",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60018805",
            "affiliation-country": "Australia"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60016849",
            "affilname": "University of Toronto",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60016849",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Toronto",
            "@id": "60015765",
            "affilname": "Centre for Addiction and Mental Health",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60015765",
            "affiliation-country": "Canada"
        },
        {
            "affiliation-city": "Warszawa",
            "@id": "60014383",
            "affilname": "Polish Academy of Sciences",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/60014383",
            "affiliation-country": "Poland"
        },
        {
            "affiliation-city": "London",
            "@id": "122106107",
            "affilname": "CRC",
            "@href": "https://api.elsevier.com/content/affiliation/affiliation_id/122106107",
            "affiliation-country": "United Kingdom"
        }
    ],
    "funding": [
        "Ratchadapiseksompotch Fund",
        "Asahi Glass Foundation",
        "Chulalongkorn University",
        "Faculty of Medicine, Chulalongkorn University"
    ]
}